Akari Therapeutics Plc (AKTX)
0.3801
+0.03
(+8.29%)
USD |
NASDAQ |
Dec 10, 16:00
0.3801
0.00 (0.00%)
After-Hours: 07:34
Akari Therapeutics Total Liabilities (Quarterly): 22.69M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 57.64M |
| Cellectis SA | 242.57M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 8.601M |
| Autolus Therapeutics Plc | 396.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.38M |
| Shareholders Equity (Quarterly) | 22.69M |
| Debt to Equity Ratio | 0.0933 |
| Current Ratio | 0.1892 |
| Net Debt Paydown Yield | -1.29% |